GILD Annual Revenue
$27.12 B
-$165.00 M-0.60%
31 December 2023
Summary:
As of January 20, 2025, GILD annual revenue is $27.12 billion, with the most recent change of -$165.00 million (-0.60%) on December 31, 2023. During the last 3 years, it has risen by +$2.43 billion (+9.83%). GILD annual revenue is now -16.92% below its all-time high of $32.64 billion, reached on December 31, 2015.GILD Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GILD Quarterly Revenue
$7.54 B
+$592.00 M+8.51%
30 September 2024
Summary:
As of January 20, 2025, GILD quarterly revenue is $7.54 billion, with the most recent change of +$592.00 million (+8.51%) on September 30, 2024. Over the past year, it has increased by +$431.00 million (+6.06%). GILD quarterly revenue is now -11.30% below its all-time high of $8.51 billion, reached on December 31, 2015.GILD Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GILD TTM Revenue
$28.30 B
+$495.00 M+1.78%
30 September 2024
Summary:
As of January 20, 2025, GILD TTM revenue is $28.30 billion, with the most recent change of +$495.00 million (+1.78%) on September 30, 2024. Over the past year, it has increased by +$1.18 billion (+4.36%). GILD TTM revenue is now -13.83% below its all-time high of $32.84 billion, reached on March 31, 2016.GILD TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GILD Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.6% | +6.1% | +4.4% |
| 3 y3 years | +9.8% | +6.1% | +4.4% |
| 5 y5 years | +22.6% | +6.1% | +4.4% |
GILD Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.7% | at low | at high | +20.5% | at high | +4.6% |
| 5 y | 5-year | -0.7% | +20.8% | at high | +46.7% | at high | +27.6% |
| alltime | all time | -16.9% | >+9999.0% | -11.3% | >+9999.0% | -13.8% | >+9999.0% |
Gilead Sciences Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $7.54 B(+8.5%) | $28.30 B(+1.8%) |
| June 2024 | - | $6.95 B(+4.0%) | $27.80 B(+1.3%) |
| Mar 2024 | - | $6.69 B(-6.0%) | $27.45 B(+1.2%) |
| Dec 2023 | $27.12 B(-0.6%) | $7.11 B(+0.9%) | $27.11 B(-1.0%) |
| Sept 2023 | - | $7.05 B(+6.8%) | $27.39 B(+0.0%) |
| June 2023 | - | $6.60 B(+3.9%) | $27.38 B(+1.3%) |
| Mar 2023 | - | $6.35 B(-14.0%) | $27.04 B(-0.9%) |
| Dec 2022 | $27.28 B(-0.1%) | $7.39 B(+4.9%) | $27.28 B(+0.5%) |
| Sept 2022 | - | $7.04 B(+12.5%) | $27.14 B(-1.4%) |
| June 2022 | - | $6.26 B(-5.0%) | $27.52 B(+0.2%) |
| Mar 2022 | - | $6.59 B(-9.0%) | $27.47 B(+0.6%) |
| Dec 2021 | $27.30 B(+10.6%) | $7.24 B(-2.4%) | $27.30 B(-0.6%) |
| Sept 2021 | - | $7.42 B(+19.4%) | $27.48 B(+3.2%) |
| June 2021 | - | $6.22 B(-3.2%) | $26.64 B(+4.2%) |
| Mar 2021 | - | $6.42 B(-13.4%) | $25.56 B(+3.5%) |
| Dec 2020 | $24.69 B(+10.0%) | $7.42 B(+12.8%) | $24.69 B(+6.7%) |
| Sept 2020 | - | $6.58 B(+27.9%) | $23.15 B(+4.4%) |
| June 2020 | - | $5.14 B(-7.3%) | $22.17 B(-2.4%) |
| Mar 2020 | - | $5.55 B(-5.6%) | $22.72 B(+1.2%) |
| Dec 2019 | $22.45 B(+1.5%) | $5.88 B(+4.9%) | $22.45 B(+0.4%) |
| Sept 2019 | - | $5.60 B(-1.4%) | $22.36 B(+0.0%) |
| June 2019 | - | $5.68 B(+7.7%) | $22.36 B(+0.2%) |
| Mar 2019 | - | $5.28 B(-8.9%) | $22.32 B(+0.9%) |
| Dec 2018 | $22.13 B(-15.2%) | $5.79 B(+3.6%) | $22.13 B(-0.7%) |
| Sept 2018 | - | $5.60 B(-0.9%) | $22.28 B(-3.9%) |
| June 2018 | - | $5.65 B(+11.0%) | $23.20 B(-6.0%) |
| Mar 2018 | - | $5.09 B(-14.5%) | $24.69 B(-5.4%) |
| Dec 2017 | $26.11 B(-14.1%) | $5.95 B(-8.6%) | $26.11 B(-5.0%) |
| Sept 2017 | - | $6.51 B(-8.8%) | $27.48 B(-3.5%) |
| June 2017 | - | $7.14 B(+9.8%) | $28.47 B(-2.2%) |
| Mar 2017 | - | $6.50 B(-11.1%) | $29.10 B(-4.2%) |
| Dec 2016 | $30.39 B(-6.9%) | $7.32 B(-2.4%) | $30.39 B(-3.8%) |
| Sept 2016 | - | $7.50 B(-3.5%) | $31.58 B(-2.5%) |
| June 2016 | - | $7.78 B(-0.2%) | $32.37 B(-1.4%) |
| Mar 2016 | - | $7.79 B(-8.4%) | $32.84 B(+0.6%) |
| Dec 2015 | $32.64 B(+31.1%) | $8.51 B(+2.5%) | $32.64 B(+3.8%) |
| Sept 2015 | - | $8.29 B(+0.6%) | $31.45 B(+7.7%) |
| June 2015 | - | $8.24 B(+8.6%) | $29.19 B(+6.2%) |
| Mar 2015 | - | $7.59 B(+3.8%) | $27.48 B(+10.4%) |
| Dec 2014 | $24.89 B(+122.2%) | $7.31 B(+21.1%) | $24.89 B(+20.3%) |
| Sept 2014 | - | $6.04 B(-7.5%) | $20.70 B(+18.7%) |
| June 2014 | - | $6.54 B(+30.7%) | $17.44 B(+27.6%) |
| Mar 2014 | - | $5.00 B(+60.2%) | $13.67 B(+22.0%) |
| Dec 2013 | $11.20 B(+15.5%) | $3.12 B(+12.1%) | $11.20 B(+5.0%) |
| Sept 2013 | - | $2.78 B(+0.6%) | $10.67 B(+3.5%) |
| June 2013 | - | $2.77 B(+9.3%) | $10.31 B(+3.6%) |
| Mar 2013 | - | $2.53 B(-2.2%) | $9.95 B(+2.6%) |
| Dec 2012 | $9.70 B(+15.7%) | $2.59 B(+6.6%) | $9.70 B(+4.2%) |
| Sept 2012 | - | $2.43 B(+0.9%) | $9.31 B(+3.4%) |
| June 2012 | - | $2.41 B(+5.4%) | $9.01 B(+3.1%) |
| Mar 2012 | - | $2.28 B(+3.7%) | $8.74 B(+4.2%) |
| Dec 2011 | $8.39 B(+5.5%) | $2.20 B(+3.7%) | $8.39 B(+2.5%) |
| Sept 2011 | - | $2.12 B(-0.7%) | $8.18 B(+2.3%) |
| June 2011 | - | $2.14 B(+11.0%) | $8.00 B(+2.7%) |
| Mar 2011 | - | $1.93 B(-3.6%) | $7.79 B(-2.0%) |
| Dec 2010 | $7.95 B(+13.4%) | $2.00 B(+3.1%) | $7.95 B(-0.4%) |
| Sept 2010 | - | $1.94 B(+0.5%) | $7.98 B(+1.7%) |
| June 2010 | - | $1.93 B(-7.6%) | $7.85 B(+3.7%) |
| Mar 2010 | - | $2.09 B(+2.6%) | $7.57 B(+7.9%) |
| Dec 2009 | $7.01 B(+31.4%) | $2.03 B(+12.8%) | $7.01 B(+9.4%) |
| Sept 2009 | - | $1.80 B(+9.4%) | $6.41 B(+7.2%) |
| June 2009 | - | $1.65 B(+7.6%) | $5.98 B(+6.6%) |
| Mar 2009 | - | $1.53 B(+7.2%) | $5.61 B(+5.1%) |
| Dec 2008 | $5.34 B(+26.1%) | $1.43 B(+4.2%) | $5.34 B(+6.7%) |
| Sept 2008 | - | $1.37 B(+7.3%) | $5.00 B(+6.7%) |
| June 2008 | - | $1.28 B(+1.6%) | $4.69 B(+5.2%) |
| Mar 2008 | - | $1.26 B(+14.9%) | $4.46 B(+5.4%) |
| Dec 2007 | $4.23 B | $1.09 B(+3.4%) | $4.23 B(+4.8%) |
| Sept 2007 | - | $1.06 B(+1.0%) | $4.03 B(+8.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2007 | - | $1.05 B(+1.9%) | $3.72 B(+10.8%) |
| Mar 2007 | - | $1.03 B(+14.4%) | $3.36 B(+11.1%) |
| Dec 2006 | $3.03 B(+49.2%) | $899.23 M(+20.1%) | $3.03 B(+10.6%) |
| Sept 2006 | - | $748.73 M(+9.3%) | $2.74 B(+10.3%) |
| June 2006 | - | $685.30 M(-1.1%) | $2.48 B(+8.3%) |
| Mar 2006 | - | $692.88 M(+13.7%) | $2.29 B(+12.9%) |
| Dec 2005 | $2.03 B(+53.1%) | $609.27 M(+23.5%) | $2.03 B(+13.4%) |
| Sept 2005 | - | $493.45 M(-0.4%) | $1.79 B(+10.3%) |
| June 2005 | - | $495.27 M(+15.1%) | $1.62 B(+12.1%) |
| Mar 2005 | - | $430.41 M(+16.5%) | $1.45 B(+9.2%) |
| Dec 2004 | $1.32 B(+52.6%) | $369.58 M(+13.3%) | $1.32 B(+8.7%) |
| Sept 2004 | - | $326.19 M(+2.0%) | $1.22 B(+11.5%) |
| June 2004 | - | $319.72 M(+3.4%) | $1.09 B(+8.0%) |
| Mar 2004 | - | $309.13 M(+17.3%) | $1.01 B(+16.6%) |
| Dec 2003 | $867.86 M(+85.9%) | $263.52 M(+31.5%) | $867.86 M(+15.8%) |
| Sept 2003 | - | $200.37 M(-16.1%) | $749.37 M(+9.7%) |
| June 2003 | - | $238.87 M(+44.7%) | $682.99 M(+23.4%) |
| Mar 2003 | - | $165.10 M(+13.8%) | $553.48 M(+18.6%) |
| Dec 2002 | $466.79 M(+99.7%) | $145.03 M(+8.2%) | $466.79 M(+17.8%) |
| Sept 2002 | - | $133.98 M(+22.5%) | $396.09 M(+26.5%) |
| June 2002 | - | $109.36 M(+39.5%) | $313.02 M(+23.1%) |
| Mar 2002 | - | $78.42 M(+5.5%) | $254.35 M(+8.8%) |
| Dec 2001 | $233.77 M(+19.5%) | $74.33 M(+46.0%) | $233.77 M(+8.9%) |
| Sept 2001 | - | $50.91 M(+0.4%) | $214.70 M(+2.8%) |
| June 2001 | - | $50.69 M(-12.4%) | $208.88 M(+0.3%) |
| Mar 2001 | - | $57.84 M(+4.7%) | $208.32 M(+5.1%) |
| Dec 2000 | $195.56 M(+15.7%) | $55.27 M(+22.6%) | $198.19 M(+3.4%) |
| Sept 2000 | - | $45.09 M(-10.1%) | $191.73 M(+3.6%) |
| June 2000 | - | $50.13 M(+5.1%) | $185.04 M(+3.7%) |
| Mar 2000 | - | $47.71 M(-2.2%) | $178.45 M(+5.6%) |
| Dec 1999 | $169.00 M(+11.8%) | $48.80 M(+27.1%) | $169.01 M(+3.9%) |
| Sept 1999 | - | $38.40 M(-11.8%) | $162.61 M(+4.2%) |
| June 1999 | - | $43.54 M(+13.7%) | $156.11 M(+30.6%) |
| Mar 1999 | - | $38.28 M(-9.7%) | $119.58 M(+26.0%) |
| Dec 1998 | $151.10 M(+14.2%) | $42.40 M(+32.9%) | $94.90 M(-38.7%) |
| Sept 1998 | - | $31.90 M(+355.7%) | $154.70 M(+21.1%) |
| June 1998 | - | $7.00 M(-48.5%) | $127.70 M(-9.0%) |
| Mar 1998 | - | $13.60 M(-86.7%) | $140.40 M(+6.1%) |
| Dec 1997 | $132.30 M(+296.1%) | $102.20 M(+1985.7%) | $132.30 M(+268.5%) |
| Sept 1997 | - | $4.90 M(-75.1%) | $35.90 M(-35.5%) |
| June 1997 | - | $19.70 M(+258.2%) | $55.70 M(+45.8%) |
| Mar 1997 | - | $5.50 M(-5.2%) | $38.20 M(+14.0%) |
| Dec 1996 | $33.40 M(+1137.0%) | $5.80 M(-76.5%) | $33.50 M(+20.9%) |
| Sept 1996 | - | $24.70 M(+1022.7%) | $27.70 M(+575.6%) |
| June 1996 | - | $2.20 M(+175.0%) | $4.10 M(+46.4%) |
| Mar 1996 | - | $800.00 K(-27.3%) | $2.80 M(-33.3%) |
| Dec 1995 | $2.70 M(-44.9%) | - | - |
| Sept 1995 | - | $1.10 M(+22.2%) | $4.20 M(-10.6%) |
| June 1995 | - | $900.00 K(0.0%) | $4.70 M(-4.1%) |
| Mar 1995 | - | $900.00 K(-30.8%) | $4.90 M(-3.9%) |
| Mar 1995 | $4.90 M(+19.5%) | - | - |
| Dec 1994 | - | $1.30 M(-18.8%) | $5.10 M(+4.1%) |
| Sept 1994 | - | $1.60 M(+45.5%) | $4.90 M(+14.0%) |
| June 1994 | - | $1.10 M(0.0%) | $4.30 M(+2.4%) |
| Mar 1994 | $4.10 M(-2.4%) | $1.10 M(0.0%) | $4.20 M(+2.4%) |
| Dec 1993 | - | $1.10 M(+10.0%) | $4.10 M(+2.5%) |
| Sept 1993 | - | $1.00 M(0.0%) | $4.00 M(0.0%) |
| June 1993 | - | $1.00 M(0.0%) | $4.00 M(-2.4%) |
| Mar 1993 | $4.20 M(+50.0%) | $1.00 M(0.0%) | $4.10 M(-18.0%) |
| Dec 1992 | - | $1.00 M(0.0%) | $5.00 M(+11.1%) |
| Sept 1992 | - | $1.00 M(-9.1%) | $4.50 M(+21.6%) |
| June 1992 | - | $1.10 M(-42.1%) | $3.70 M(+32.1%) |
| Mar 1992 | $2.80 M(+115.4%) | $1.90 M(+280.0%) | $2.80 M(+33.3%) |
| Dec 1991 | - | $500.00 K(+150.0%) | $2.10 M(+23.5%) |
| Sept 1991 | - | $200.00 K(0.0%) | $1.70 M(+6.3%) |
| June 1991 | - | $200.00 K(-83.3%) | $1.60 M(+6.7%) |
| Mar 1991 | $1.30 M | $1.20 M(+1100.0%) | $1.50 M(+400.0%) |
| Dec 1990 | - | $100.00 K(0.0%) | $300.00 K(+50.0%) |
| Sept 1990 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| June 1990 | - | $100.00 K | $100.00 K |
FAQ
- What is Gilead Sciences annual revenue?
- What is the all time high annual revenue for Gilead Sciences?
- What is Gilead Sciences annual revenue year-on-year change?
- What is Gilead Sciences quarterly revenue?
- What is the all time high quarterly revenue for Gilead Sciences?
- What is Gilead Sciences quarterly revenue year-on-year change?
- What is Gilead Sciences TTM revenue?
- What is the all time high TTM revenue for Gilead Sciences?
- What is Gilead Sciences TTM revenue year-on-year change?
What is Gilead Sciences annual revenue?
The current annual revenue of GILD is $27.12 B
What is the all time high annual revenue for Gilead Sciences?
Gilead Sciences all-time high annual revenue is $32.64 B
What is Gilead Sciences annual revenue year-on-year change?
Over the past year, GILD annual revenue has changed by -$165.00 M (-0.60%)
What is Gilead Sciences quarterly revenue?
The current quarterly revenue of GILD is $7.54 B
What is the all time high quarterly revenue for Gilead Sciences?
Gilead Sciences all-time high quarterly revenue is $8.51 B
What is Gilead Sciences quarterly revenue year-on-year change?
Over the past year, GILD quarterly revenue has changed by +$431.00 M (+6.06%)
What is Gilead Sciences TTM revenue?
The current TTM revenue of GILD is $28.30 B
What is the all time high TTM revenue for Gilead Sciences?
Gilead Sciences all-time high TTM revenue is $32.84 B
What is Gilead Sciences TTM revenue year-on-year change?
Over the past year, GILD TTM revenue has changed by +$1.18 B (+4.36%)